Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts are needed to develop alternative therapies for this type of cancer. Immunotherapy, as a novel strategy in cancer treatment, has a potential in treating breast cancer patients. Although breast cancer has long been considered problematic to treat with immunotherapy, as it is immunologically "cold," numerous newer preclinical and clinical reports now recommend that immunotherapy has the capability to treat breast cancer patients. In this review, we highlight the different immunotherapy strategies in breast cancer treatment.
Simonian,M , Haji Ghaffari,M and Negahdari,B . (2021). Immunotherapy for Breast Cancer Treatment. Iranian Biomedical Journal, 25(3), 140-156. doi: 10.52547/ibj.25.3.140
MLA
Simonian,M , , Haji Ghaffari,M , and Negahdari,B . "Immunotherapy for Breast Cancer Treatment", Iranian Biomedical Journal, 25, 3, 2021, 140-156. doi: 10.52547/ibj.25.3.140
HARVARD
Simonian M, Haji Ghaffari M, Negahdari B. (2021). 'Immunotherapy for Breast Cancer Treatment', Iranian Biomedical Journal, 25(3), pp. 140-156. doi: 10.52547/ibj.25.3.140
CHICAGO
M Simonian, M Haji Ghaffari and B Negahdari, "Immunotherapy for Breast Cancer Treatment," Iranian Biomedical Journal, 25 3 (2021): 140-156, doi: 10.52547/ibj.25.3.140
VANCOUVER
Simonian M, Haji Ghaffari M, Negahdari B. Immunotherapy for Breast Cancer Treatment. Iranian Biomedical Journal. 2021;25(3):140-156. doi: 10.52547/ibj.25.3.140
Iranian Biomedical Journal